Lung Cancer Master Protocol (Lung-MAP), a public-private partnership, established infrastructure for conducting a biomarker-driven master protocol in molecularly targeted therapies. We compared ...

Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab. Use of formative evaluation surveying and tailored digital education to identify ...